You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed multiple myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Miami, Florida
    University of Miami
May 31, 2023

Multiple Myeloma Trial in Hangzhou (BCMA CAR-T cells injection)

Recruiting
  • Multiple Myeloma
  • BCMA CAR-T cells injection
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Feb 13, 2023

Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

Terminated
Has Results
  • Multiple Myeloma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 28, 2022

Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)

Recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Sep 21, 2023

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

Recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Manufactured Anti-BCMA CAR-T cells
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Hangzhou (BCMA Targeted CAR T-cells)

Recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
  • BCMA Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Medical College, Zhejiang Univers
Jun 18, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Rapid Infusion Isatuximab)

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Rapid Infusion Isatuximab
  • (no location specified)
Jul 3, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Elotuzumab, Selinexor, and Dexamethasone (ESd)
  • (no location specified)
Apr 27, 2022

Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,

Recruiting
  • Multiple Myeloma in Relapse
  • Daratumumab/Lenalidomide/Dexamethasone for 24 months
  • Daratumumab/Lenalidomide/Dexamethasone until progression
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Jun 10, 2022

Relapsed Multiple Myeloma in France in Context of Carfilzomib

Completed
  • Relapsed Multiple Myeloma
    • Le Mans, France
      Centre Hospitalier Du Mans
    Mar 8, 2022

    NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

    Recruiting
    • NHL
    • +6 more
    • Minneapolis, Minnesota
    • +2 more
    Nov 7, 2023

    Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • Relapsed and/or Refractory Multiple Myeloma
    • Köln, Germany
      Local Institution - 0017
    Dec 4, 2023

    Multiple Myeloma Trial (AZD0305)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 24, 2023

    Multiple Myeloma Trial (CM313 injection)

    Not yet recruiting
    • Multiple Myeloma
    • CM313 injection
    • (no location specified)
    Nov 6, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Suzhou, Jiangsu, China
      First Affiliated Hospital, Soochow University
    Jul 31, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ISB 2001
    • Benowa, Queensland, Australia
      Pindara Private Hospital
    May 18, 2023

    Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Sep 20, 2023

    Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

    Not yet recruiting
    • Relapsed Cancer
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jun 19, 2023

    Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • YTS104 Cells injection
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jun 13, 2023

    Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

    Not yet recruiting
    • Relapsed and Refractory Multiple Myeloma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Sep 15, 2023

    Multiple Myeloma Trial in Wollongong (IBI3003)

    Not yet recruiting
    • Multiple Myeloma
    • Wollongong, New South Wales, Australia
      Wollongong Private Hospital
    Oct 18, 2023